Treatment Details – 12.4 months

Survival: 12.4 months
Toxicity Grade:
Treatments: Surgery
Hospital:Medical University of Vienna
Date: 4/2008

Patients: This study involved forty-nine patients with malignant pleural mesothelioma. There were 10 women and 39 men, with a median age of 59 years, ranging from 28 to 81.
Some had previously been treated with chemotherapy drugs such as pemetrexed, cisplatin, gemcitabine, carboplatin, and doxorubicin.

Treatment: Patients were treated with surgery, extrapleural pneumonectomy.

Toxicity: Complications from surgery included atrial fibrillation, laryngeal nerve palsy, temporary paraplegia, and stroke.

Results: The median overall survival was 12.4 months (376 days).

Correspondence: Dr. Walter Klepetko

Get your free copy of
“Surviving Mesothelioma” Today!